louisiana semaglutide constipation class action nausea legal team in attorney semaglutide constipation law office louisiana Charleston Ozempic Lawyer louisiana semaglutide constipation attorney semaglutide – glp-1 gi obstruction lawsuit in – semaglutide constipation class action in

U.MehtaV.RenzuM.PereiraK.AR

Key Industry Developments In March 2026 , China approved Pfizers once-weekly injectable GLP-1 weight-loss drug Xianweiying (ecnoglutide) for long-term weight management in overweight or obese adults, strengthening Pfizers position in the rapidly expanding obesity therapeutics market

This effect relates to increased thermogenesis from glucagon receptor activation

GLP-1 receptor agonists have demonstrated efficacy in managing both conditions by improving glycemic control and promoting weight loss, making them increasingly prescribed therapeutic options

Blurred vision and focusing difficulties are among the most commonly reported semaglutide-related vision issues